EGFR Signaling Networks in Cancer Therapy

The epidermal growth factor (EGF) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGFR therapies. Edited by John Haley and William J. Gullick...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Haley, John D. (Επιμελητής έκδοσης), Gullick, William John (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Totowa, NJ : Humana Press, 2008.
Σειρά:Cancer Drug Discovery and Development
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04479nam a22004695i 4500
001 978-1-59745-356-1
003 DE-He213
005 20151204174118.0
007 cr nn 008mamaa
008 100301s2008 xxu| s |||| 0|eng d
020 |a 9781597453561  |9 978-1-59745-356-1 
024 7 |a 10.1007/978-1-59745-356-1  |2 doi 
040 |d GrThAP 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 616.994  |2 23 
245 1 0 |a EGFR Signaling Networks in Cancer Therapy  |h [electronic resource] /  |c edited by John D. Haley, William John Gullick. 
264 1 |a Totowa, NJ :  |b Humana Press,  |c 2008. 
300 |a XI, 395 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Cancer Drug Discovery and Development 
505 0 |a EGFR Signaling Networks -- EGFR Receptor Family Extracellular Domain Structures and Functions -- EGFR family heterodimers in cancer pathogenesis and treatment -- Structure-function of EGFR kinase domain and its inhibitors -- Internalization and degradation of EGF receptor -- Differential dependence of EGFR and ErbB2 on the molecular chaperone Hsp90 -- Activation of STATs 3 and 5 Through the EGFR Signaling Axis -- The intersection of EGFR and the Ras signaling pathway -- PHOSPHOINOSITIDE 3-KINASE ENZYMES AS DOWNSTREAM TARGETS OF THE EGF RECEPTOR -- Convergence of EGF Receptor and Src Family Signaling Networks in Cancer -- A Molecular Crosstalk between E-cadherin and EGFR Signaling Networks -- Crosstalk Between Insulin-like Growth Factor (IGF) and Epidermal Growth Factor (EGF) Receptors -- Negative regulation of signaling by the EGFR family -- Nuclear ErbB Receptors: Pathways and Functions -- Temporal Dynamics of EGF Receptor Signaling by Quantitative Proteomics -- Computational and Mathematical Modelling of the EGF Receptor System -- EGFR in Tumorigenesis and EGFR Tyrosine Kinase Inhibitors in Cancer Therapy -- Expression and prognostic significance of the EGFR in solid tumors -- Signalling by the EGF receptor in human cancers: accentuate the positive, eliminate the negative -- EGFR signaling in invasion, angiogenesis and metastasis -- Constitutive activation of truncated EGF receptors in glioblastoma -- EGFR Mutations, Other Molecular Alterations Related To Sensitivity to EGFR Inhibitors, and Molecular Testing for EGFR-Targeted Therapies in Non-Small Cell Lung Cancer -- Crosstalk Between COX-2 and EGFR: A Potential Therapeutic Opportunity -- Cellular sensitivity to EGF receptor inhibitors -- Utilizing combinations of molecular targeted agents to sensitize tumor cells to EGFR inhibitors. 
520 |a The epidermal growth factor (EGF) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGFR therapies. Edited by John Haley and William J. Gullick, EGFR Signaling Networks in Cancer Therapy, is separated into two sections. The first of which probes the molecular pathways and the intersection of signaling networks which are frequently deregulated in human cancers, with a view to describing EGF receptor in a tumor tissue specific context. Meanwhile, the second section illustrates the many ways in which EGF receptor contribute to abnormal survival and migration signaling in cancer cells and to epithelial to mesenchymal transition and metastasis. The book also describes the mitogenic, survival, adhesive and migratory pathways within a framework of interacting subsystems that contribute to the activity and physiological regulation of the receptor in normal and neoplastic tissues. Even though there is still much to learn, this volume explores this fascinating system with compelling information. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Oncology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Oncology. 
650 2 4 |a Cancer Research. 
700 1 |a Haley, John D.  |e editor. 
700 1 |a Gullick, William John.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781588299482 
830 0 |a Cancer Drug Discovery and Development 
856 4 0 |u http://dx.doi.org/10.1007/978-1-59745-356-1  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)